AEON icon

AEON Biopharma
AEON

Overview Fund Activity

26 hedge funds and large institutions have $103M invested in AEON Biopharma in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
8
Increased
10
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.37M
2
Goldman Sachs
Goldman Sachs
New York
+$1.75M
3
Millennium Management
Millennium Management
New York
+$649K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$648K
5
State Street
State Street
Massachusetts
+$574K

Top Sellers

1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$2.32M
2
Northern Trust
Northern Trust
Illinois
-$11.7K
3
UBS Group
UBS Group
Switzerland
-$4.67K
4
Bank of America
Bank of America
North Carolina
-$4.18K
5
DCM
Dupont Capital Management
Delaware
-$22
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
26
Dupont Capital Management
Delaware
$35 -$22 – –
Macquarie Group
27
Macquarie Group
Australia
$10 +$10 +13 New
UBS Group
28
UBS Group
Switzerland
– -$4.67K -9 Closed
1
2